Results 91 to 100 of about 8,702,161 (252)

DrugECs: An Ensemble System with Feature Subspaces for Accurate Drug-Target Interaction Prediction [PDF]

open access: yes, 2017
Background. Drug-target interaction is key in drug discovery, especially in the design of new lead compound. However, the work to find a new lead compound for a specific target is complicated and hard, and it always leads to many mistakes.
Jun Zhang   +4 more
core   +1 more source

A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma

open access: yesFEBS Letters, EarlyView.
Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos   +9 more
wiley   +1 more source

Recommendation techniques for drug–target interaction prediction and drug repositioning

open access: yes, 2016
The usage of computational methods in drug discovery is a common practice. More recently, by exploiting the wealth of biological knowledge-bases, a novel approach called Drug-Repositioning has raised.
Alaimo, S   +8 more
core   +1 more source

Leveraging Image-Derived Phenotypic Measurements for Drug-Target Interaction Predictions

open access: yesCancer Informatics, 2019
In recent years, protein kinases have become some of the most significant drug targets in cancer patients. Kinases are known to regulate the activity of many human proteins, and consequently their inhibition has been used to control cancer proliferation.
Srikanth Kuthuru   +4 more
doaj   +1 more source

The ubiquitin system in normal and infected germinal center B cells

open access: yesFEBS Letters, EarlyView.
The ubiquitin system plays a central role in germinal center (GC) B cells, influencing differentiation to long‐lived memory B cells. Oncogenic gammaherpesviruses gain access to memory B cells by establishing latency in GC B cells. Mapping ubiquitin mechanisms in normal and infected GC B cells will define specific molecular circuits in B cells germane ...
Destiny Davis   +2 more
wiley   +1 more source

Smaller is better: nanobodies meet NMR

open access: yesFEBS Letters, EarlyView.
Nanobodies are single‐domain antigen‐binding fragments derived from camelid heavy chain antibodies. Their small size, high stability, and exceptional specificity make nanobodies uniquely useful probes for NMR studies of protein dynamics, transient conformational states, and protein–protein interactions.
Oleg Y. Dmitriev
wiley   +1 more source

Neutralization of the PTX3/CD44 axis suppresses TGF‐β1 signaling in kidney fibrosis

open access: yesFEBS Letters, EarlyView.
This study investigates how the PTX3/CD44 axis promotes kidney fibrosis by activating TGF‐β1 signaling. We demonstrate that the neutralizing antibody WHC‐001 effectively inhibits this pathway, suppressing myofibroblast activation and partial epithelial–mesenchymal transition (EMT).
Chao‐Chun Cheng   +8 more
wiley   +1 more source

MOTIVE: A Drug-Target Interaction Graph For Inductive Link Prediction [PDF]

open access: yes
Drug-target interaction (DTI) prediction is crucial for identifying new therapeutics and detecting mechanisms of action. While structure-based methods accurately model physical interactions between a drug and its protein target, cell-based assays such as
Arevalo, John   +3 more
core   +1 more source

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces

open access: yesBMC Bioinformatics, 2019
Background Detection of new drug-target interactions by computational algorithms is of crucial value to both old drug repositioning and new drug discovery.
Yi Zheng   +5 more
doaj   +1 more source

Drug-gene target prioritization.

open access: yes, 2018
Drug-gene target prioritization.
Rozemarijn S. van Rijn (4898842)   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy